WHO forecasts that in 2023 the number of patients with coronary atherosclerosis in the world will reach over 41 million people. As a result, the coronary artery bypass surgery is the most frequently performed cardiac surgery procedure in the world today.
Usually the patient's own saphenous vein is used as a bypass. As a result of high blood pressure and other factors, the vessel rebuilds and its wall thickens - which unfortunately happens inward. This leads to a restriction of the vessel's patency.
External stent aims to:
Increasing population and extending life expectancy give atherosclerosis more time to develop in more and more people. According to the current state of art in medicine, the best way to help patients is to increase the blood supply to the coronary arteries by implanting a bypass. The more developed the atherosclerosis of the coronary arteries, the stronger are the indications for surgery.
We have created a revolutionary external stent that has the potential to improve the patency of bypasses and extend and improve the quality of life for millions of people around the world.
This is why it is so important to constantly optimize the CABG procedure. It will translate into the life expectancy and quality of life for millions of people.
Our solution is to maintain the patency of the venous bypass grafts, which is still an unsolved problem in cardiac surgery. The ultimate goal is greater comfort and longer life for coronary heart disease patients.Piotr Denis, CEO Stentsolution
Marcin Skrodzki is an experienced project manager in the medical devices industry, who has led research and development initiatives over recent years, focusing on the study and implementation of innovative medical devices.